Pfizer updates inhaled-insulin label; link to lung cancer eyed

BOSTON (MarketWatch) -- Pfizer Inc. is updating the labeling on Exubera, its troubled inhaled-insulin product, to reflect that a small number of patients taking the drug had developed lung cancer, the company said Wednesday. 7 months ago